CommonHealth, a Free Mobile App for Patients to Share Health Data – including COVID Test and Vaccine Status – Connects to 230 US Health Systems
● CommonHealth, a free service run by a nonprofit, has connected to 230 health systems…
News
StageZero Life Sciences Ltd. Announces Closing of Public Offering for Proceeds of $7.2 million
NOT FOR DISTRIBUTION OR DISSEMINATION INTO THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES TORONTO,…
Adial Pharmaceuticals Lead Drug Candidate AD04 for Treatment of Alcohol Use Disorder Featured in Follow-up TV News Story
Previous news segment has appeared on dozens of media stations nationwide CHARLOTTESVILLE, VA / ACCESSWIRE…
CureVac Appoints Antony Blanc as Chief Business Officer and Chief Commercial Officer
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / December 4, 2020 / CureVac N.V. (NASDAQ:CVAC),…
Jaguar Health and its Subsidiary, Napo Pharmaceuticals, Enter into Fifth Amendment to the Accounts Receivable Purchase Agreement with Oasis Capital, LLC, Dated May 12, 2020
The Sixth Tranche Accounts Receivable has a gross value of $3,810,587.04, representing customer billings over…
Avinger Expands Tigereye(TM) Limited Launch
REDWOOD CITY, CA / ACCESSWIRE / December 4, 2020 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage…
Sparta Appoints Mr. Leonard Shara, P.Eng. to Technical Advisory Board
TORONTO, ON / ACCESSWIRE / December 4, 2020 / Sparta Group (TSXV:SAY) (the “Corporation” the…
Philips boosts digital pathology with enhanced informatics to advance precision diagnosis in oncology
Care team reviewing histopathology slides Pathologist reviewing histopathology slides Pathologist reviewing histopathology slides on 2…
Brain Scientific to Showcase Disposable EEG Headset NeuroCap™ at American Epilepsy Society Annual Meeting
NEW YORK, Dec. 04, 2020 (GLOBE NEWSWIRE) — via InvestorWire – Brain Scientific Inc. (OTCQB:…
Y-mAbs and Takeda Announce Exclusive License and Distribution Agreement for DANYELZA® (naxitamab-gqgk) and Omburtamab in Israel
NEW YORK and PETACH TIKVA, Israel, Dec. 04, 2020 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc….